Wolverine World Wide insider exercises options and sells 12,854 shares
Rhea-AI Filing Summary
Insider option exercise and sale on 08/27/2025: Brenda J. Lauderback exercised a stock option to acquire 12,854 shares of Wolverine World Wide, Inc. at an exercise price of $19.25 per share and simultaneously sold 12,854 shares at a weighted-average sale price of $32.14 per share. After these transactions she beneficially owned 48,675 shares directly. The option exercised was granted with an original grant/exercise schedule showing exercisability from 04/21/2016 and expiration 04/20/2026. The filing discloses the weighted-average sale price range and notes multiple sale prices between $31.95 and $32.31.
Positive
- Exercise and sale fully disclosed: The Form 4 reports exercise of options and sale details with a weighted-average sale price and explanatory note.
- Realized value capture: Shares were sold at a weighted-average $32.14 versus the $19.25 exercise price, reflecting a clear economic gain for the reporting person.
- Remaining direct ownership disclosed: Beneficial ownership after the transactions is stated as 48,675 shares.
Negative
- Insider decreased holdings: The reporting person sold 12,854 shares, reducing direct holdings from 61,529 to 48,675 shares.
- Sale executed across multiple prices: The sale occurred at prices ranging from $31.95 to $32.31, requiring further detail for exact allocation by price (the filer offers to provide it on request).
Insights
TL;DR: Routine option exercise and contemporaneous sale realizing spread; ownership remains meaningful but reduced.
From a capital-markets perspective, this is a standard Section 16 transaction where the reporting person exercised an in-the-money option (exercise price $19.25) and immediately sold the same number of shares at a weighted-average $32.14, capturing the intrinsic spread. The filing shows no change to derivative exposure post-transaction and a remaining direct holding of 48,675 shares. There is no indication of additional planned transactions or hedging arrangements in the filing itself. For investors, the activity documents liquidity realization by an insider rather than a change in corporate control or a dilutive issuance.
TL;DR: Compliance filing meets Section 16 disclosure; transaction appears routine and properly reported.
The Form 4 discloses exercise and sale executed on 08/27/2025 and includes the required explanatory note about multiple sale prices. The signature is by power of attorney, which is disclosed. Beneficial ownership after the reported transactions is explicitly stated. The filing contains no statements of a Rule 10b5-1 plan or other special arrangements, and no governance issues or material events are raised by the data provided.